Colin, T., Margue, G., Gross-Goupil, M., Bigot, P., Barthélémy, P., Albiges, L., Ferrer, L., Bernhard, J. (2026). Individualized recurrence risk prediction as a challenge to conventional eligibility criteria in phase III adjuvant immunotherapy trials for renal cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16501